Brincidofovir for reducing infectious polyomavirus production
WO2025253179A1PCT designated stage Publication Date: 2025-12-11SYMBIO PHARM LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PCT/IB2025/000294
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-06-06
- Filing Date
- 2025-06-05
- Publication Date
- 2025-12-11
Smart Images
Figure IB2025000294_11122025_PF_FP_ABST
Abstract
A method of reducing infectious polyomavirus production in the brain or kidney of a human subject in need thereof, the method comprising administering a therapeutically effective amount of brincidofovir (BCV) or a pharmaceutically acceptable salt thereof to the human subject. A method of decreasing the risk of infectious polyomavirus production in the brain or kidney of a human subject in need thereof, the method comprising administering a therapeutically effective amount of brincidofovir (BCV) or a pharmaceutically acceptable salt thereof to the human subject.
Need to check novelty before this filing date? Find Prior Art